Dr. Kroener is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10666 N Torrey Pines Rd
La Jolla, CA 92037Phone+1 858-554-8629
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1981
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1977 - 1979
- University of California (San Diego) Medical CenterInternship, Internal Medicine, 1976 - 1977
- University of California San Diego School of MedicineClass of 1976
Certifications & Licensure
- CA State Medical License 1977 - 2018
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
Publications & Presentations
PubMed
- 24 citationsA randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast cancer.Adam Brufsky, Karen Hoelzer, Thaddeus Beck, Robert C. Whorf, Mark Keaton
Clinical Breast Cancer. 2011-08-01 - 124 citationsPhase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast CancerMassimo Cristofanilli, Vicente Valero, Aroop Mangalik, Melanie Royce, Ian Rabinowitz
Clinical Cancer Research. 2010-03-15 - 241 citationsBenefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowe...Eleftherios P. Mamounas, Jong-Hyeon Jeong, D. Lawrence Wickerham, Roy E. Smith, Patricia A. Ganz
Journal of Clinical Oncology. 2008-04-20
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: